Mimedx Group, Inc. SEC filings MDXG

Mimedx Group, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Nov 5, 2012. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 28, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.

Mimedx Group, Inc. SEC filings
Form Description Filed Period
ARS Annual report to shareholders Apr 29, 2026 Dec 31, 2025
10-K Annual report Feb 25, 2026 Dec 31, 2025
ARS Annual report to shareholders May 23, 2025 Dec 31, 2024
10-K Annual report Feb 26, 2025 Dec 31, 2024
10-K Annual report Feb 28, 2024 Dec 31, 2023
10-K/A Amended annual report May 1, 2023 Dec 31, 2022
10-K Annual report Feb 28, 2023 Dec 31, 2022
10-K Annual report Feb 28, 2022 Dec 31, 2021
10-K Annual report Mar 8, 2021 Dec 31, 2020
10-K Annual report Jul 6, 2020 Dec 31, 2019
10-K Annual report Mar 17, 2020 Dec 31, 2018
10-K Annual report Mar 1, 2017 Dec 31, 2016
10-K/A Amended annual report Feb 22, 2017 Dec 31, 2015
10-K Annual report Feb 29, 2016 Dec 31, 2015
ARS Annual report to shareholders Apr 14, 2015 Dec 31, 2014
10-K Annual report Mar 13, 2015 Dec 31, 2014
10-K/A Amended annual report Apr 30, 2014 Dec 31, 2013
10-K Annual report Mar 4, 2014 Dec 31, 2013
10-K Annual report Mar 15, 2013 Dec 31, 2012

Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
MDXG (Nasdaq)
Fiscal year ends
December 31
Headquarters
Marietta, GA
SEC filer status
Large accelerated filer
SEC CIK
1376339
Former names
Alynx, Co. (until Apr 2, 2008)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.